| |
 |
|
Class Information
Number: 514/182
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618956 |
Reduction of hair growth |
Nov. 17, 2009 |
| 7605152 |
17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
Oct. 20, 2009 |
| 7601708 |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
Oct. 13, 2009 |
| 7601706 |
Bile-acid conjugates providing for sustained systemic concentration of drugs |
Oct. 13, 2009 |
| 7598235 |
Bile-acid conjugates for providing sustained systemic concentrations of drugs |
Oct. 6, 2009 |
| 7598234 |
Steroid derived antibiotics |
Oct. 6, 2009 |
| 7572779 |
Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Aug. 11, 2009 |
| 7572781 |
Prodrugs for use as ophthalmic agents |
Aug. 11, 2009 |
| 7553830 |
Compositions for the delivery of negatively charged molecules |
Jun. 30, 2009 |
| 7553829 |
Treatment of chronic fatigue syndrome and fibromyalgia syndrome |
Jun. 30, 2009 |
| 7550452 |
Cationic lipids and use thereof |
Jun. 23, 2009 |
| RE40792 |
Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
Jun. 23, 2009 |
| 7544673 |
Coating compositions for bioactive agents |
Jun. 9, 2009 |
| 7538100 |
17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediate products for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as we |
May. 26, 2009 |
| 7534780 |
Estradiol prodrugs |
May. 19, 2009 |
| 7528123 |
Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
May. 5, 2009 |
| 7524835 |
Tetrol steroids and esters |
Apr. 28, 2009 |
| 7524836 |
Nitrooxyderivative steroidal compounds |
Apr. 28, 2009 |
| 7521068 |
Dry powder aerosols of nanoparticulate drugs |
Apr. 21, 2009 |
| 7514472 |
Fat or oil composition |
Apr. 7, 2009 |
| 7514420 |
Steroids having 1,8-unsaturation and formulations comprising same |
Apr. 7, 2009 |
| 7514099 |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
Apr. 7, 2009 |
| 7507725 |
Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
Mar. 24, 2009 |
| 7501403 |
Bile acid or bile salt fatty acid conjugates |
Mar. 10, 2009 |
| 7501409 |
Preparations for oral administration |
Mar. 10, 2009 |
| 7498322 |
Antiangiogenic agents |
Mar. 3, 2009 |
| 7494680 |
Fat or oil composition |
Feb. 24, 2009 |
| 7473687 |
Methods for the treatment of a traumatic central nervous system injury |
Jan. 6, 2009 |
| 7459445 |
Estrogenic compounds and topical pharmaceutical formulations of the same |
Dec. 2, 2008 |
| 7456161 |
Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease |
Nov. 25, 2008 |
| 7427610 |
2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
Sep. 23, 2008 |
| 7419972 |
2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17.beta.-hydroxy steroid dehydrogenase type 1 |
Sep. 2, 2008 |
| 7414043 |
9-.alpha.-substituted estratrienes as selectively active estrogens |
Aug. 19, 2008 |
| 7410959 |
Therapeutic uses for aminosterol compounds |
Aug. 12, 2008 |
| 7387786 |
Food additive compositions containing sterol esters, solubilizing agents, dispersants and antioxidants |
Jun. 17, 2008 |
| 7384926 |
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
Jun. 10, 2008 |
| 7381848 |
Estrogenic compounds as anti-mitotic agents |
Jun. 3, 2008 |
| 7381416 |
Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics |
Jun. 3, 2008 |
| 7378404 |
8.beta.-hydrocarbyl-substituted estratrienes for use as selective estrogens |
May. 27, 2008 |
| 7378406 |
Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
May. 27, 2008 |
| 7375098 |
8.beta.-vinyl-11.beta.-(.omega.-substituted)alkyl-estra-1,3,5(10)-trienes |
May. 20, 2008 |
| 7371741 |
Estradiol derivatives and pharmaceutical compositions using same |
May. 13, 2008 |
| 7351699 |
Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent |
Apr. 1, 2008 |
| 7345035 |
Treatment of osteoporosis and autoimmune disease with astrogorgiadiol |
Mar. 18, 2008 |
| 7342004 |
Thioether sulphamate steroids as steroid inhibitors and anti-cancer compounds |
Mar. 11, 2008 |
| 7320969 |
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
Jan. 22, 2008 |
| 7312207 |
Topical steroid cream formulations |
Dec. 25, 2007 |
| 7297688 |
Starter kit for low dose oral contraceptives |
Nov. 20, 2007 |
| 7291610 |
Estrogenic compounds as anti-mitotic agents |
Nov. 6, 2007 |
| RE39861 |
Methods of extended use oral contraception |
Sep. 25, 2007 |
|
|
|
